Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions

AIM: To investigate daclatasvir (DCV) and asunaprevir (ASV) efficacy in hepatitis C (HCV) patients, with respect to resistance-associated substitutions (RASs). METHODS: A total of 392 HCV-infected patients from multiple centers were included in this study. We evaluated their clinical courses and sus...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Hepatol
Autors principals: Fujii, Hideki, Umemura, Atsushi, Nishikawa, Taichiro, Yamaguchi, Kanji, Moriguchi, Michihisa, Nakamura, Hideki, Yasui, Kohichiroh, Minami, Masahito, Tanaka, Saiyu, Ishikawa, Hiroki, Kimura, Hiroyuki, Takami, Shiro, Nagao, Yasuyuki, Shima, Toshihide, Itoh, Yoshito
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2017
Matèries:
Retrospective Cohort Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596313/
https://ncbi.nlm.nih.gov/pubmed/28951778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v9.i25.1064
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars